NCT01771081 - Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy | Biotech Hunter

Enrollment

911

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

April 30, 2015

Conditions

OphthalmologyMacular EdemaMacular Degeneration

Interventions

DRUG

Ranibizumab (or other DME treatment)

Patients with DME having started treatment with an approved anti-VEGF therapy at or after 01 October 2012 and then continuing with this or any kind or no treatment

Trial Locations (8)

Unknown

Many Locations